Latest News
New BioPharma Contracts Signed During Q3 2022 Valued at $12.8 Million
Revenue recognition commencing in September to October timeframe. Average length of each program is approximately 12 months. TORONTO, ON, March 29, 2022 – Think Research Corporation (TSXV:THNK) (“Think” or the “Company”), a healthcare technology company focused on...
BioPharma Services Achieves Another Successful FDA Inspection Result
TORONTO, ON - June 16, 2022 - Think Research Corporation (TSXV:THNK) (OTCQB: THKKF) (“Think” or the “Company”), a company focused on transforming healthcare through digital health software solutions, is pleased to announce its subsidiary, BioPharma Services Inc.,...
BioPharma Services Receives 2022 Biotechnology Award from GHP
TORONTO, ON, April 29, 2022 – Slated for being a Leading Provider of Pharma Product of Clinical Trial Services in 2022, BioPharma Services Inc. is happy to announce its acceptance of the Biotechnology Award for this year. Presented by Global Health & Pharma...
BioPharma Services Receives Pharma Tech Outlook Top 10 CRO’s of 2022 Award
TORONTO, ON, April 28, 2022 – BioPharma Services Inc. is delighted to announce the acceptance of the Pharma Tech Outlook Top CRO's of 2022 award. Pharma Tech Outlook is a print and digital magazine that provides a knowledge network for scaling pharma technology...
Events
We look forward to meeting you at industry conferences virtually and in person, when possible.
Schedule a Discovery Call
Learn how BioPharma Services can be your trusted clinical trial partner.